Thursday 8 December 2016

Pfizer fined a record £84.2m for overcharging

Pfizer fined a record £84.2m for overcharging Pharmaceutical giant Pfizer has been fined a record £84.2 million for charging the NHS “excessive and unfair prices”.

The Competition and Markets Authority (CMA) imposed the fine, along with a £5.2 million fine on the distributor Flynn Pharma, after finding each broke competition law “by charging excessive and unfair prices in the UK” for the anti-epilepsy drug phenytoin sodium capsules.

The CMA has ordered the companies to reduce their prices, but Pfizer says it will appeal the decision. OnMedica

No comments:

Post a Comment